By Buck Daniel – With each passing day we are closer to having our clients paid with funds from the $650 million dollar settlement agreed to in mid-2014. Unfortunately, as described in the Master Settlement Agreement, the value for each injury category will be slightly less than first estimated. Our […]
Pradaxa
7 posts
By Buck Daniel May 29, 2014 – The Nations Law Firm is pleased to announce the settlement of all of its Pradaxa claims against Boehringer Ingelheim. The pharmaceutical company will pay $650 million to settle all 4,000 state and federal lawsuits over its blood thinner Pradaxa (dabigatran). In 2011 alone, […]
By Buck Daniel – March 31, 2014 – The Court overseeing our Pradaxa cases made slight changes to the bellwether discovery and trial schedule. The Plaintiffs’ Steering Committee was given additional time to disclose experts, and the first bellwether trial will begin September 8, 2014. The Court denied Defendants’ motion […]
By Buck Daniel August 14, 2013 – More than 700 Pradaxa cases have now been filed in the Southern District of Illinois before Judge David Herndon. The majority of these cases claim gastrointestinal bleeding injuries, but there have also been many catastrophic bleeding events such as hemorrhagic stroke. Judge Herndon has […]
Posted by Amber Stanford June 12, 2012 – More reports were made against the controversial new blood-thinner, Pradaxa, than any other drug on the market last year. And according to the Institute for Safe Medicine Practices’ (ISMP), Pradaxa also topped the list for reports of deaths, hemorrhage, acute renal failure, […]
By Shelley Blas May 31, 2012 – A motion was filed late last night in the product liability case involving Pradaxa. The petition seeks transfer of nearly a dozen pending cases, and all future claims, to a centralized docket in the U.S. District Court for the Southern District of Illinois. […]
By Andrea Schmauss April 14, 2012 – Houston, Texas attorney Howard Nations, the immediate past president of The National Trial Lawyers, is taking on the manufacturer of Pradaxa, a blood thinning drug which the FDA is investigating for possibly causing serious, possibly fatal bleeding. Doctors prescribe Pradaxa to help reduce […]